Stocks
Charles River Laboratories International () EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 581.7 | 759.1 | 854.3 | 1 036 | 1 032 | 990.4 | ||
| Changes by years, y/y, % | +42% | +30% | +13% | +21% | 0% | +20.3% | |||
Charles River Laboratories International. EBITDA US GAAP, bln rub
Charles River Laboratories International. EBITDA US GAAP, changes, %
Charles River Laboratories International. EBITDA US GAAP, sum by quarters, bln rub
Charles River Laboratories International () EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA, bln rub | ? | 225.5 | 322.8 | 219.4 | 238.5 | 209.7 | 990.4 | |
| Changes by years, y/y, % | +8% | +2% | -10% | -1% | -7% | |||
| Changes by quarters, q/q, % | -7% | +43% | -32% | +9% | -12% | |||
